VolitionRx Company
VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.
Founded Date:
2010-01-01
Funding Status:
IPO
Total Funding:
44327746.0
Headquarters:
Singapore, Central Region, Singapore
Last Funding Date:
2023-02-17
Investors Number:
1.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
Less than $1M
Industry:
Clinical Development